Nattaporn Phanthaphol

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma

Kamonlapat Supimon, Thanich Sangsuwannukul, Jatuporn Sujjitjoon et al. · Scientific Reports · 2021 · 59 citations · Full text

Current Treatments, Immunology, Immune Regulation +23

Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells

Thanich Sangsuwannukul, Kamonlapat Supimon, Jatuporn Sujjitjoon et al. · International Immunopharmacology · 2020 · 46 citations

Tumor Immunology, Cholangiocarcinoma Cells, Cancer Immunosurveillance +8

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells

Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri et al. · Frontiers in Oncology · 2021 · 42 citations · Full text

Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells

Aussara Panya, Chutamas Thepmalee, Nunghathai Sawasdee et al. · Cancer Immunology Immunotherapy · 2018 · 36 citations · Full text

Cancer Immunosurveillance, Biliary Cancer, T-regulatory Cell +8

Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells

Methi Wathikthinnakon, Piriya Luangwattananun, Nunghathai Sawasdee et al. · Scientific Reports · 2022 · 28 citations · Full text